From the floor in Chengdu: 22 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Pricing
Page 19 of 25 of this archive, newest first.
Argentina caps liraglutide prescribing to 5 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What the placebo arms of the withdrawal trials actually tell us
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
From the floor in Xianning: 23 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Mexico caps dulaglutide prescribing to 18 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
The United Arab Emirates declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The United Arab Emirates declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
What happens when the drug is taken away: three randomised answers
Three randomised withdrawal designs have tested what happens when treatment stops. Their results are consistent and they are consistently misreported.
India declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The supply gap as a clinical event
Why the reason for stopping changes what happens afterwards.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Randomised withdrawal is the cleanest design in this field and the least discussed
A withdrawal trial answers a narrower question than it appears to. This piece states which question.
The lowest effective dose is a real concept with almost no data behind it
The commonest real-world strategy in this drug class is the least studied one.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Weight regain is not a failure of willpower and it is not a mystery
The variance around the mean regain trajectory is large and unexplained, exactly as it is for the weight loss.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
From the floor in Nantong: 24 posters, one theme
Reported from the sessions, and from the two hours afterwards.